SEER INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
SEER INC. - More news...
SEER INC. - More news...
- Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021
- Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program
- Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
- Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
- Seer Appoints Meeta Gulyani to its Board of Directors
- Seer to Participate in the Piper Sandler Virtual Healthcare Conference
- Seer Reports Third Quarter 2021 Financial Results
- Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors
- Seer to Report Third Quarter Financial Results on November 9, 2021
- Seer to Present at the Morgan Stanley Global Healthcare Conference
- Seer Reports Second Quarter 2021 Financial Results
- Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China
- Seer to Report Second Quarter Financial Results on August 12, 2021
- Seer Reports First Quarter 2021 Financial Results
- Seer to Present at the BofA Securities 2021 Healthcare Conference
- Seer to Report First Quarter Financial Results on May 10, 2021
- Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions
- Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships
- Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
- Seer to Present at the Cowen 41st Annual Healthcare Conference
- Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors
- Seer Announces Closing of Public Offering of Common Stock
- Seer Announces Pricing of Upsized Public Offering of Common Stock
- Seer Announces Proposed Public Offering of Common Stock
- Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics
- Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
- Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference
- Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
